Skip to content

GenMark up on emergency use application for SARS-CoV-2 test

August 17, 2020

GenMark Diagnostics (NASDAQ:GNMK) has filed an application with the FDA seeking emergency use authorization for its eSensor SARS-CoV-2 Test, a molecular assay that detects the presence of the coronavirus.

The test is performed on the company’s multiplex molecular diagnostic system called the XT-8 that can generate results from 96 samples in five hours.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: